To evaluate whether the results in BCs can be translated into other HER2-overexpressing entities, similar experiments have been conducted in NSCLC (DV90, NCI-H1781, A549) and CRC (LS411N, DLD1, COLO201) cell lines (Fig. 2, S1, S3). The gene discussed is ERBB2; the disease is colorectal carcinoma.